It was reported that RANKL-targeted peptides inhibited osteoclastogenesis and attenuated adjuvant-induced arthritis by inhibiting RANKL activation and downregulating inflammatory cytokines (Naidu et al., 2013). Here, TNFSF11 is linked to Arthritis.